TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, May 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 14,004 followers.

TITAN: Phase III Study of Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage TNBC https://t.co/Th4usBwScz

RT @pablodesaavedra: PHASE III study of doxorubicin/cyclophosphamide early-stage triple-negative breast cancer. https://t.co/YFiR9k4Bkp

PHASE III study of doxorubicin/cyclophosphamide early-stage triple-negative breast cancer. https://t.co/YFiR9k4Bkp

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in… https://t.co/yNXdlh6kqn #breastcancer